Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes

Journal of NeuroVirology

Volumn 11, Issue 4, 2005, Pages 384-394

  Ahlqvist, Jenny ^a,b   Fotheringham, Julie ^a   Akhyani, Nahid ^a   Yao, Karen ^a   Fogdell Hahn, Anna ^b   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Human herpesvirus 6; Latency; MO3.13; Multiple sclerosis; Oligodendrocytes

Indexed keywords

GLYCOPROTEIN GP 116; GLYCOPROTEIN GP 54; GLYCOPROTEIN GP 64; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS DNA; VIRUS GLYCOPROTEIN; VIRUS RNA; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DISEASE COURSE; HERPES SIMPLEX; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HYPOTHESIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; NEUROLOGIC DISEASE; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; VIROGENESIS; VIRUS LATENCY; VIRUS LOAD; VIRUS PATHOGENESIS; CELL LINE; CYTOLOGY; EXANTHEMA SUBITUM; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MULTIPLE SCLEROSIS; PATHOLOGY; T LYMPHOCYTE; VIROLOGY; VIRUS ENCEPHALITIS;

DNA VIRUSES; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 6;

ANTIGENS, VIRAL; CELL LINE; ENCEPHALITIS, VIRAL; EXANTHEMA SUBITUM; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 6, HUMAN; HUMANS; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; RNA, MESSENGER; T-LYMPHOCYTES; VIRUS LATENCY;

EID: 27144501566     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280591002379     Document Type: Article

References (61)

1. Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B, Salahuddin SZ, Gallo RC (1991). Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 184: 545-552.
2. Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, McFarland HF, Jacobson S (2000). Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 182: 1321-1325.
3. Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, Gonzalez-Scarano F (1998). The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J NeuroVirol 4: 486-494.
4. Alvarez-Lafuente R, De las Heras V, Bartolome M, Picazo JJ, Arroyo R (2004). Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol 61: 1523-1527.
5. Arbour N, Cote G, Lachance C, Tardieu M, Cashman NR, Talbot PJ (1999a). Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol 73: 3338-3350.
6. Arbour N, Ekande S, Cote G, Lachance C, Chagnon F, Tardieu M, Cashman NR, Talbot PJ (1999b). Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol 73: 3326-3237.
7. Arsenault S, Gravel A, Gosselin J, Flamand L (2003). Generation and characterization of a monoclonal antibody specific for human herpesvirus 6 variant A immediate-early 2 protein. J Clin Virol 28: 284-290.
8. Asano Y, Yoshikawa T, Kajita Y, Ogura R, Suga S, Yazaki T, Nakashima T, Yamada A, Kurata T (1992). Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 67: 1484-1485.
9. Braun DK, Dominguez G, Pellett PE (1997). Human herpesvirus 6. Clin Microbiol Rev 10: 521-567.
10. Buntinx M, Vanderlocht J, Hellings N, Vandenabeele F, Lambrichts I, Raus J, Ameloot M, Stinissen P, Steels P (2003). Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J Neurocytol 32: 25-38.
11. Carrigan DR, Harrington D, Knox KK (1996). Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology 47: 145-148.
12. Caserta MT, Hall CB, Schnabel K, McIntyre K, Long C, Costanzo M, Dewhurst S, Insel R, Epstein LG (1994). Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 170: 1586-1589.
13. Cermelli C, Berti R, Soldan SS, Mayne M, D'Ambrosia JM, Ludwin SK, Jacobson S (2003). High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 187: 1377-1387.
14. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, et al. (1995). Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92: 7440-7444.
15. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M (2003). Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol 69: 111-117.
16. Cuomo L, Trivedi P, Cardillo MR, Gagliardi FM, Vecchione A, Caruso R, Calogero A, Frati L, Faggioni A, Ragona G (2001). Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 63: 45-51.
17. DeBolle L, Van Loon J, De Clercq E, Naesens L (2005). Quantitative analysis of human herpesvirus 6 cell tropism. J Med Virol 75: 76-85.
18. Dewburst S, McIntyre K, Schnabel K, Hall CB (1993). Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol 31: 416-418.
19. Dietrich J, Blumberg BM, Roshal M, Baker JV, Hurley SD, Mayer-Proschel M, Mock DJ (2004). Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J Neurosci 24: 4875-4883.
20. Dockrell DH, Paya CV (2001). Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 11: 23-36.
21. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE (1999). Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 73: 8040-8052.
22. Donati D, Akhyani N, Fogdell-Halm A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A, Heiss JD, Cogen P, Gaillard WD, Sato S, Theodore WH, Jacobson S (2003). Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61: 1405-1411.
23. Drobyski WR, Knox KK, Majewski D, Carrigan DR (1994). Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 330: 1356-0360.
24. Fraser NW, Lawrence WC, Wroblewska Z, Gilden DH, Koprowski H (1981). Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A 78: 6461-6465.
25. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM (2003). Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 187: 1365-1376.
26. Hall CB, Caserta MT, Schnabel KC, Long C, Epstein LG, Insel RA, Dewhurst S (1998). Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 26: 132-137.
27. Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, Knott A, Dewhurst S, Insel RA, Epstein LG (1994). Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 331: 432-438.
28. Hummel M, Abecassis MM (2002). A model for reactivation of CMV from latency. J Clin Virol 25(Suppl 2): S123-S136.
29. Isegawa Y, Mukai T, Nakano K, Kagawa M, Chen J, Mori Y, Sunagawa T, Kawanishi K, Sashihara J, Hata A, Zou P, Kosuge H, Yamanishi K (1999). Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 73: 8053-8063.
30. Ishiguro N, Yamada S, Takahashi T, Takahashi Y, Togashi T, Okuno T, Yamanishi K (1990). Meningo-encephalitis associated with HHV-6 related exanthem subitum. Acta Paediatr Scand 79: 987-989.
31. Jones CM, Dunn HG, Thomas EE, Cone RW, Weber JM (1994). Acute encephalopathy and status epilepticus associated with human herpes virus 6 infection. Dev Med Child Neurol 36: 646-650.
32. Kamei A, Ichinohe S, Onuma R, Hiraga S, Fujiwara T (1997). Acute disseminated derayelination due to primary human herpesvirus-6 infection. Eur J Pediatr 156: 709-712.
33. Knox KK, Carrigan DR (1995). Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 9: 69-73.
34. Kondo K, Shimada K, Sashihara J, Tanaka-Taya K, Yamanishi K (2002). Identification of human herpesvirus 6 latency-associated transcripts. J Virol 76: 4145-4151.
35. Kong H, Baerbig Q, Duncan L, Shepel N, Mayne M (2003). Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death. J NeuroVirol 9: 539-550.
36. Kurtzke JF (1995). MS epidemiology world wide. One view of current status. Acta Neurol Scand Suppl 161: 23-33.
37. Kurz SK, Rapp M, Steffens HP, Grzimek NK, Schmalz S, Reddehase MJ (1999). Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 73: 482-494.
38. Levy JA, Ferro F, Greenspan D, Lennette ET (1990). Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 335: 1047-1050.
39. Luppi M, Barozzi P, Maiorana A, Marasca R, Trovato R, Fano R, Ceccherini-Nelli L, Torelli G (1995). Human herpesvirus-6: a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors. J Med Virol 47: 105-111.
40. Mackenzie IR, Carrigan DR, Wiley CA (1995). Chronic myelopathy associated with human herpesvirus-6. Neurology 45: 2015-2017.
41. Markovic-Plese S, McFarland HF (2001). Immunopathogenesis of the multiple sclerosis lesion. Curr Neurol Neurosci Rep 1: 257-262.
42. McLaurin J, Trudel GC, Shaw IT, Antel JP, Cashman NR (1995). A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol 26: 283-293.
43. Mock DJ, Powers JM, Goodman AD, Blumenthal SR, Ergin N, Baker JV, Mattson DH, Assouline JG, Bergey EJ, Chen B, Epstein LG, Blumberg BM (1999). Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy. J NeuroVirol 5: 363-373.
44. Nitsche A, Muller CW, Radonic A, Landt O, Ellerbrok H, Pauli G, Siegert W (2001). Human herpesvirus 6A DNA Is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 183: 130-133.
45. Novoa LJ, Nagra RM, Nakawatase T, Edwards-Lee T, Tourtellotte WW, Cornford ME (1997). Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. J Med Virol 52: 301-308.
46. Opsahl ML, Kennedy PG (2005). Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 128: 516-527.
47. Plumb J, Duprex WP, Cameron CH, Richter-Landsberg C, Talbot P, McQuaid S (2002). Infection of human oligodendroglioma cells by a recombinant measles virus expressing enhanced green fluorescent protein. J NeuroVirol 8: 24-34.
48. Rotola A, Merlotti I, Caniatti L, Caselli E, Granieri E, Tola MR, Di Luca D, Cassai E (2004). Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult Scler 10: 348-354.
49. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S (2000). Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 47: 306-313.
50. Suga S, Yoshikawa T, Asano Y, Kozawa T, Nakashima T, Kobayashi I, Yazaki T, Yamamoto H, Kajita Y, Ozaki T, et al (1993). Clinical and virological analyses of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications. Ann Neurol 33: 597-603.
51. Wagner M, Muller-Berghaus J, Schroeder R, Sollberg S, Luka J, Leyssens N, Schneider B, Krueger GR (1997). Human herpesvirus-6 (HHV-6)-associated necrotizing encephalitis in Griscelli's syndrome. J Med Virol 53: 306-312.
52. Wainwright MS, Martin PL, Morse RP, Lacaze M, Provenzale JM, Coleman RE, Morgan MA, Hulette C, Kurtzberg J, Bushnell C, Epstein L, Lewis DV (2001). Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 50: 612-619.
53. Weinshenker BG, Wilton S, Rice GP (1988). Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J Immunol 140: 1625-1631.
54. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T (1988). Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 1065-1067.
55. Yanagihara K, Tanaka-Taya K, Itagaki Y, Toribe Y, Arita K, Yamanishi K, Okada S (1995). Human herpesvirus 6 meningoencephalitis with sequelae. Pediatr Infect Dis J 14: 240-242.
56. Yasukawa M, Ohminami H, Sada E, Yakushijin Y, Kaneko M, Yanagisawa K, Kohno H, Bando S, Fujita S (1999a). Latent infection and reactivation of human herpesvirus 6 in two novel myeloid cell lines. Blood 93: 991-999.
57. Yasukawa M, Sada E, MacHino H, Fujita S (1999b). Reactivation of human herpesvirus 6 in pityriasis rosea. Br J Dermatol 140: 169-170.
58. Yoshikawa T, Asano Y, Akimoto S, Ozaki T, Iwasaki T, Kurata T, Goshima F, Nishiyama Y (2002). Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol 66: 497-505.
59. Zerr DM, Gooley TA, Yeung L, Huang ML, Carpenter P, Wade JC, Corey L, Anasetti C (2001). Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 33: 763-771.
60. Zerr DM, Yeung LC, Obrigewitch RM, Huang ML, Frenkel LM, Corey L (2002). Case report: primary human herpesvirus-6 associated with an afebrile seizure in a 3-week-old infant. J Med Virol 66: 384-387.
61. Zou P, Isegawa Y, Nakano K, Haque M, Horiguchi Y, Yamanishi K (1999). Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol 73: 5926-5933.